TSNDF
TerrAscend Corp.1.1300
+0.2310+25.7%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
420.07MP/E (TTM)
28.25Basic EPS (TTM)
0.04Dividend Yield
0%Recent Filings
8-K
Closes Union Chill option deal
TerrAscend closed its Union Chill transaction on December 26, 2025, securing a 35% option in the high-performing New Jersey dispensary for $9M in 6.5% convertible notes and $4M cash upon exercise. This expands its NJ footprint to four stores, with the dispensary generating over $11M annualized revenue. Immediately accretive to EBITDA. Federal enforcement risks persist.
8-K
Q3 revenue steady, margins up
TerrAscend posted Q3 net revenue of $65.1 million from continuing operations, steady year-over-year, with gross margin up to 52.1% and adjusted EBITDA margin at 26.1%. Cash from operations hit $7.1 million—13th straight positive quarter—bolstered by $79 million debt refinancing and $35 million M&A facility. Michigan exit on track by year-end. Balance sheet strengthened.
10-Q
Q3 FY2025 results
TerrAscend held Q3 revenue steady at $65.1M, flat y/y but with gross margin expanding 1.1 points to 52.1% on cultivation efficiencies that offset wholesale pricing pressure. Operating income swung to $11.1M from $7.3M y/y (derived), fueled by 14% G&A cuts from lower stock-based comp. Cash climbed to $36.5M on $25.6M operating cash flow (continuing ops), funding $6.9M capex for $18.7M FCF (derived); debt rose to $230M principal via $79M FG Loan upsizing that retired Pelorus and other facilities, maintaining covenant compliance. Ratio Ohio assets closed May 2025 for $10.1M (cash/note/shares), adding $2.8M goodwill and $6.7M 15-year license. Michigan exit drags with $61M YTD discontinued loss from $41M impairments. Federal illegality persists.
8-K
Q2 results and Michigan exit
TerrAscend reported Q2 2025 net revenue of $65 million from continuing operations, down 3.3% year-over-year, with gross profit margin expanding to 51.1% and adjusted EBITDA of $16 million at 24.6% margin. The company announced its Michigan exit to slash debt and sharpen focus on core Northeast markets, where retail revenue climbed sequentially amid expansions in New Jersey and Maryland. Post-quarter, it secured a $79 million non-dilutive term loan extending maturities to 2028, unlocking up to $35 million more for M&A. Cash flow stays positive—12 quarters running.
10-Q
Q2 FY2025 results
TerrAscend's Q2 revenue dipped 3% y/y to $65.0M while holding steady q/q, with gross profit flat at $33.2M and margins edging up to 51.1% on tighter costs. Operating income rose 3% y/y to $11.0M, but net loss from continuing operations narrowed just 2% to $6.4M as high taxes ($9.6M) offset gains. YTD, revenue fell 5% to $129.3M with operating income up 16% to $23.2M and diluted EPS improving to -$0.06 from -$0.07, reconciled to 296M shares. Free cash flow (derived) of $13.8M trailed last year's $29.2M amid $5.1M spent on the Ratio Cannabis acquisition in May for $10.1M (cash/stock/note), adding $2.8M goodwill and a 15-year license intangible. Cash stood at $26.7M against $212.1M debt, bolstered by a post-quarter $79M loan upsize. Michigan exit drags with a $35.0M impairment; federal illegality under the Controlled Substances Act looms large.
IPO
Website
Employees
Sector
Industry
AAWH
Ascend Wellness Holdings, Inc.
0.99+0.21
ACB
Aurora Cannabis Inc.
5.53+0.41
AYRWF
AYR WELLNESS INC.
0.03+0.01
CANN
TREES Corporation
0.05-0.00
CBSTF
THE CANNABIST COMPANY HOLDINGS
0.10+0.03
CRLBF
Cresco Labs Inc.
1.75+0.45
CURLF
Curaleaf Holdings, Inc.
4.53+0.85
LEEEF
LEEF BRANDS INC
0.22+0.02
TCNNF
Trulieve Cannabis Corporation
10.58+1.31
VEXTF
Vext Science Inc.
0.22+0.01